Royalty Pharma has been a great trade. While the S&P 500 was flat, the stock price has climbed by 17.3% to $33.06 per share.

Cross Timbers Royalty Trust (NYSE:CRT – Get Free Report) saw a large decline in short interest in the month of March. As of ...

HighTower Advisors LLC decreased its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.0% during the 4th quarter, ...

Sandstorm Gold’s Q4 2024 revenue rose despite a decline in GEOs. See why SAND stock is a solid buy, with a growth outlook ...

PrairieSky will release its Q1 2025 results on Monday, April 14, 2025 after markets close. The news release detailing ...

Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.

This well-known Canadian company constantly generates significant cash flow, making it an ideal dividend stock for passive-income seekers. The post A 6.8% Dividend Stock Paying Cash Every Month ...

National Bank keeps an Outperform rating and $2.10 price target on Gold Royalty (GROY) after its Q4 results and production guidance. The stock ...

Discover February's top-performing precious metals stocks, with Sailfish Royalty leading at 11.11% growth. Click here to read ...

Doubled the royalty and milestone portfolio to over 120 royalty assets with significant milestone potential through five transactions in ...

Getty Images stock price has crashed to a record low as concerns about its growth and AI disruption continue. GETY slumped to ...